ArticleDiscover oncology2023

Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study).

Wan-Soo Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.